COVID-19

In an interview with Pharmacy Times, Stefan Behrens, PhD, CEO and co-founder of GYANT, and Justin Graham, MD, MS, chief medical officer, said preparing patients for the process of receiving a coronavirus disease 2019 (COVID-19) vaccine is essential.

This week on Pharmacy Times, there are a number of important topics that will be covered and posted throughout the week

A recent nationwide survey of 400 pharmacists conducted by the American Pharmacists Association (APhA) found that more than three-fourths of pharmacists plan to be vaccinated with 1 of the coronavirus disease 2019 (COVID-19) vaccines.

Although most people say they will receive a COVID-19 vaccine once it becomes available, 27% were unsure.

In recent years, digital health devices have offered pathways for patients to record and send data, which may ultimately encourage the patient to be more interactive in their disease management.

According to the survey results, 56% of patients with chronic obstructive pulmonary disease reported that COVID-19 has made it difficult for them to receive treatment

Proteases are important to the health and viability of cells and viruses. If proteases are inhibited, cells cannot perform many important functions, such as replication.

Following authorization allowing pharmacists to administer childhood vaccines, some pediatricians have expressed concerns that this deprives children of medical care or could lead to missed vaccines.

The researchers launched the Perinatal Experiences and COVID-19 Effects Study to better understand the mental health and well-being of pregnant and postpartum individuals within the United States during the COVID-19 pandemic.

Beta-blockers could be used as a potential treatment for COVID-19, according to a study by Italian and Australian researchers.

Warning letters requested that companies immediately stop selling these unapproved products and said consumers concerned about COVID-19 should talk to their health care provider.

COVID-19 has not stolen my final year of pharmacy school from me, but rather, has given me once in lifetime learning opportunities unique to this time in my life and in the world.

Pharmacy Times spoke with Angela Kashuba, Dean of UNC Eshelman School of Pharmacy and Patrick Brown, UNC Eshelman School of Pharmacy Alumni, about the importance of preparing pharmacists and students to vaccinate the general public with the COVID-19 vaccine.

The COVID-19 mRNA vaccine, BNT162b2, developed by Pfizer and BioNTech, has been granted a temporary authorization for emergency use against COVID-19 in the United Kingdom.

The connection between COVID-19 and sleep apnea cannot be explained by obesity rates alone.

The combination of COVID-19 with opioid-induced respiratory depression, especially in an elderly patient, could be deadly.

Researchers found that COVID-19 severity was linked to cardiovascular risk factors, such as obesity, high blood pressure, diabetes, and high cholesterol.

Secretary Azar’s emergency declaration under PREP Act allows them to procure, dispense, and administer vaccinations once available.

Students answer the question: How have campus groups or pharmacy organizations remained active during the pandemic?

Pharmacy Times spoke with Angela Kashuba, Dean of UNC Eshelman School of Pharmacy and Patrick Brown, UNC Eshelman School of Pharmacy Alumni, about preparation for the possibility of a general public COVID-19 vaccine.

Moderna intends to submit the EUA application today and believes that the FDA’s Vaccines and Related Biological Products Advisory Committee will meet to review the safety and efficacy data package on Thursday, December 17, according to the press release.

This week on Pharmacy Times, there are a number of important topics that will be covered and posted throughout the week.

Patients with COVID-19 faced a significant emotional and financial burden after discharge from treatment.

The Pharmacy Times® Pharmacy Focus podcast provides the latest industry news and information, thought-leader insights, clinical updates, patient counseling tools, and innovative solutions for the everyday practice and business of pharmacy.

In the midst of the COVID-19 pandemic, it is important that individuals who are at higher risk for poor outcomes from infection with vaccine-preventable diseases remain up-to-date with their immunizations.